Chemours Faces Investor Suit Over Alleged Exec Misconduct https://www.law360.com/compliance/articles/1816350?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-03-22&read_main=1&nlsidx=0&nlaidx=9 By Emilie Ruscoe Chemical company The Chemours Co. and four of its current and former executives face claims they hurt investors by manipulating a certain financial metric so the executives might receive greater compensation under the company's incentive plans. Complaint attached | Read full article » https://www.law360.com/compliance/articles/1816350?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-03-22&read_more=1&nlsidx=0&nlaidx=9 | Save to favorites » https://www.law360.com/compliance/articles/1816350?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-03-22&read_later=1&nlsidx=0&nlaidx=9